Litcius/Paper detail

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy

Ryuma Tokunaga, Wu Zhang, Madiha Naseem, Alberto Puccini, Martin D. Berger, Shivani Soni, Michelle McSkane, Hideo Baba, Heinz‐Josef Lenz

2017Cancer Treatment Reviews1,650 citationsDOIOpen Access PDF

Topics & Concepts

CXCL9MedicineCXCR3CXCL10Immune systemCXCL11ChemokineCancer researchAutocrine signallingImmunologyParacrine signallingImmunotherapyCancer immunotherapyCXC chemokine receptorsChemotaxisImmune checkpointCancer cellCXCL14CancerChemokine receptorInternal medicineReceptorChemokine receptors and signalingImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy | Litcius